Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
- Citation
- Winter GE,Rix U,Carlson SM,Gleixner KV,Grebien F,Gridling M,Muller AC,Breitwieser FP,Bilban M,Colinge J,Valent P,Bennett KL,White FM,Superti-Furga G. Nature chemical biology. 2012-October. Vol 8. 905-12. [pubmed]
- Description
- Quantitative measurement of phosphorylation in a BCR-ABLT315I mouse model. Treatment includes control and addition of tyrosine kinase inhibitors (bosutinib, danusertib, and the combination)
- Conditions
-
- Drug
- danusertib
- Drug
- bosutinib
- Cell
- Ba/F3 BCR-ABLT315I
- Date Loaded
- May 23 2016
Experiment Data Summary
- Proteins
- 405
- Measured Peptides
- 564
- Modification Sites
- 841
- Rejected Peptides
- 83
| By Residue | By Modification Type | By Species | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|